Clinical Trial Update: A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated trabectedin in patients with advanced cancers and hepatic dysfunction to understand how liver impairment affects dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Disease

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Neoplasm Metastases, Hepatic Insufficiency | Phase 1 | Status: COMPLETED